Funtion of Uncharacterized Genes of Acinetobacter baumanii
鲍曼不动杆菌未表征基因的功能
基本信息
- 批准号:8688145
- 负责人:
- 金额:$ 161.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-24 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcinetobacterAcinetobacter baumanniiAntibiotic ResistanceAntibioticsAntimicrobial ResistanceBacteriaBiochemicalBiocideCell Membrane PermeabilityCell surfaceCodeCommunicable DiseasesDataDesiccationDevelopmentDisinfectantsDisinfectionDrug TargetingDrug resistanceEnzymesGenesGeneticGenomeGenomicsGoalsHospitalsIndividualInfectionKnowledgeModelingMolecularMulti-Drug ResistanceNatural ImmunityNosocomial InfectionsOpportunistic InfectionsOrganismPathogenesisPharmaceutical PreparationsPhenotypeProcessProteinsProteomicsResearchResearch ProposalsResistanceResourcesRoleSurface PropertiesTechnologyTestingTherapeuticWorkantimicrobialbasebiological adaptation to stressclinically relevantdata managementefflux pumpenvironmental changegene functiongenetic analysishuman diseasemutantnovel strategiespathogenprogramspublic health relevancerelational databaseresponsescreeningtrait
项目摘要
DESCRIPTION (provided by applicant): Acinetobacter baumannii (Ab) is an emerging pathogen that causes primary and opportunistic infections, and is a serious concern in the hospital and battlefield setting. This organism has significant intrinsic resistance to antibioticsas well as an ability to quickly acquire new resistance. Additionally, Ab can persist in a desiccated state on fomites, making disinfection and management of nosocomial infections particularly troublesome. The goal of this research proposal is to find unexploited therapeutic approaches by elucidating the role of uncharacterized genes of Ab in this organism's mechanisms of pathogenesis, resistance, and persistence. Three projects will be established to 1) use a genomic approach to broadly identify the role of uncharacterized genes (Colin Manoil, Project 1 Director) 2) determine the role of envelope integrity with regard to bacterial viability (Sam Mille, PI/PD, Project 2 Director), and use expression analysis to identify genes and sRNAs of unknown function associated with drug, disinfectant, and desiccation tolerance (Carrie Harwood, Project 3 Director). The work of the Center will be supported by an Administrative Core (Core 1, John Kemner Core Leader), a Protein Interaction Technology Core (Jim Bruce Core 2 Director Leader), and a Data Dissemination/Resource Management Core (Mitch Brittnacher, Core 3 Director).
描述(由申请人提供):鲍曼尼(AB)杆菌(AB)是一种新兴的病原体,会引起原发性和机会性感染,并且在医院和战场环境中是一个严重的关注点。该生物具有对抗生素的明显固有耐药性以及快速获得新抗性的能力。此外,AB可以坚持在Fomites上保持干燥状态,从而使医院感染的消毒和管理特别麻烦。 这项研究建议的目的是通过阐明AB在该生物体的发病机理,抗性和持久性机制中的作用来找到未开发的治疗方法。 Three projects will be established to 1) use a genomic approach to broadly identify the role of uncharacterized genes (Colin Manoil, Project 1 Director) 2) determine the role of envelope integrity with regard to bacterial viability (Sam Mille, PI/PD, Project 2 Director), and use expression analysis to identify genes and sRNAs of unknown function associated with drug, disinfectant, and desiccation tolerance (Carrie Harwood, Project 3 导演)。该中心的工作将得到行政核心(Core 1,John Kemner Core Leader),蛋白质相互作用技术核心(Jim Bruce Core 2主管领导者)和数据传播/资源管理核心(Mitch Brittnacher,Core 3 Director)的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samuel I Miller其他文献
Samuel I Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samuel I Miller', 18)}}的其他基金
Salmonella pathogenicity island 2 effector proteins
沙门氏菌致病岛2效应蛋白
- 批准号:
9526598 - 财政年份:2017
- 资助金额:
$ 161.53万 - 项目类别:
Funtion of Uncharacterized Genes of Acinetobacter baumanii
鲍曼不动杆菌未表征基因的功能
- 批准号:
8581005 - 财政年份:2013
- 资助金额:
$ 161.53万 - 项目类别:
Funtion of Uncharacterized Genes of Acinetobacter baumanii
鲍曼不动杆菌未表征基因的功能
- 批准号:
9282562 - 财政年份:2013
- 资助金额:
$ 161.53万 - 项目类别:
Funtion of Uncharacterized Genes of Acinetobacter baumanii
鲍曼不动杆菌未表征基因的功能
- 批准号:
8852062 - 财政年份:2013
- 资助金额:
$ 161.53万 - 项目类别:
Assigning function of unknown genes of Acinetobacter baumanii by cell envelope
通过细胞包膜鉴定鲍曼不动杆菌未知基因的功能
- 批准号:
8597718 - 财政年份:2013
- 资助金额:
$ 161.53万 - 项目类别:
ERIN CRC: Molecular Basis of Nontyphoidal Salmonella Emergence
ERIN CRC:非伤寒沙门氏菌出现的分子基础
- 批准号:
8123203 - 财政年份:2010
- 资助金额:
$ 161.53万 - 项目类别:
相似海外基金
Dual-Wavelength Blue Light Irradiation for Improved Treatment of Staphylococcus aureus Infections
双波长蓝光照射改善金黄色葡萄球菌感染的治疗
- 批准号:
10724476 - 财政年份:2023
- 资助金额:
$ 161.53万 - 项目类别:
Dual-Stimuli Responsive Antibiotic-Loaded Nanoparticles: A New Strategy to Overcome Antimicrobial Resistance
双刺激响应抗生素负载纳米颗粒:克服抗生素耐药性的新策略
- 批准号:
10703696 - 财政年份:2023
- 资助金额:
$ 161.53万 - 项目类别:
Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection
用于预防中心静脉导管相关血流感染的电化学导管
- 批准号:
10560927 - 财政年份:2023
- 资助金额:
$ 161.53万 - 项目类别:
Developing novel pyrazolidinone antibiotics targeting PBP3 to overcome resistance mechanisms
开发针对 PBP3 的新型吡唑烷酮抗生素以克服耐药机制
- 批准号:
10590839 - 财政年份:2023
- 资助金额:
$ 161.53万 - 项目类别: